Published on
In a retrospective study of U.S. insurance claims from 2001–2023 published in Infection Control & Hospital Epidemiology, researchers examined 4,651 measles cases to estimate the frequency and duration of diagnostic delays. During the 14 days preceding diagnosis, 426 patients (9.2%) had healthcare encounters involving symptoms potentially attributable to measles. Researchers estimated that 6.9% of patients experienced at least 1 missed diagnostic opportunity, with an average delay of 4.05 days (95% confidence interval [CI], 3.48–4.51) (median delay = 2.94 days [95% CI, 2.00–3.00]). Approximately 1.7% experienced delays of 7 days or longer. Most missed opportunities occurred in outpatient settings (81.0%), followed by emergency departments (14.4%), inpatient settings (3.9%), and observation stays (0.7%). Prescriptions for respiratory antibiotics were also associated with increased odds of delayed diagnosis (odds ratio, 6.42; 95% CI, 4.59–9.53). Although diagnostic delays affected a relatively small proportion of patients, the authors emphasize that delays can mean greater transmission opportunities for measles in healthcare settings.
Be prepared: During measles outbreaks, early recognition and testing in patients presenting with respiratory symptoms may help prevent additional infections, according to the authors. The latest Centers for Disease Control and Prevention figures show 5,182 confirmed measles cases in the United States for 2026, based on reports through November 5—approximately 126% higher than the total cases recorded for all of 2025. And measles patients are presenting to urgent care, which might motivate leaders to ensure protocols are in place and their staff is trained to handle measles patients appropriately.
